Jazz Pharmaceuticals plc is a global biopharmaceutical company focused on rare diseases, epilepsies, cancers, and sleep disorders. Its key marketed products include Xywav and Xyrem (oxybate therapies for narcolepsy and idiopathic hypersomnia), Epidiolex/Epidyolex (cannabidiol for seizures), Zepzelca (lurbinectedin for SCLC), Rylaze/Enrylaze (asparaginase for ALL/LBL), Ziihera (zanidatamab-hrii for HER2-positive BTC), and Modeyso (dordaviprone for diffuse midline glioma). The company commercializes products globally and invests in R&D to advance its rare disease pipeline.
expected 2026-11-30
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-24 | 2025-12-31 | 0001232524-26-000013 | EDGAR | 121K words |
| 2025-02-26 | 2024-12-31 | 0001232524-25-000011 | EDGAR | 123K words |
| 2024-02-28 | 2023-12-31 | 0001232524-24-000015 | EDGAR | 119K words |
| 2023-03-01 | 2022-12-31 | 0001232524-23-000015 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001232524-22-000012 | EDGAR | — |
| 2021-02-23 | 2020-12-31 | 0001232524-21-000016 | EDGAR | — |
| 2020-02-25 | 2019-12-31 | 0001232524-20-000016 | EDGAR | — |
| 2019-02-26 | 2018-12-31 | 0001232524-19-000013 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001232524-18-000018 | EDGAR | — |
| 2017-02-28 | 2016-12-31 | 0001232524-17-000024 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-03 | 2026-06-30 | 0001232524-26-000045 | EDGAR | 31K words |
| 2025-11-05 | 2025-09-30 | 0001232524-25-000074 | EDGAR | 43K words |
| 2025-08-06 | 2025-06-30 | 0001232524-25-000063 | EDGAR | 41K words |
| 2025-05-07 | 2025-03-31 | 0001232524-25-000027 | EDGAR | 39K words |
| 2024-11-07 | 2024-09-30 | 0001232524-24-000086 | EDGAR | 38K words |
| 2024-08-01 | 2024-06-30 | 0001232524-24-000068 | EDGAR | 34K words |
| 2024-05-02 | 2024-03-31 | 0001232524-24-000033 | EDGAR | 33K words |
| 2023-11-08 | 2023-09-30 | 0001232524-23-000052 | EDGAR | 38K words |
| 2023-08-09 | 2023-06-30 | 0001232524-23-000037 | EDGAR | 46K words |
| 2023-05-10 | 2023-03-31 | 0001232524-23-000026 | EDGAR | 35K words |
| 2022-11-09 | 2022-09-30 | 0001232524-22-000046 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0001232524-22-000035 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-23 | 0001193125-26-399425 | EDGAR | 142K words |
| 2026-09-15 | 0001628280-26-061978 | EDGAR | 1K words |
| 2026-08-31 | 0001193125-26-377073 | EDGAR | 2K words |
| 2026-08-25 | 0001628280-26-058864 | EDGAR | 3K words |
| 2026-08-10 | 0001193125-26-341270 | EDGAR | 2K words |
| 2026-08-10 | 0001193125-26-342667 | EDGAR | 70K words |
| 2026-08-03 | 0001232524-26-000044 | EDGAR | 10K words |
| 2026-07-24 | 0001628280-26-049466 | EDGAR | 1K words |
| 2026-02-24 | 0001232524-26-000012 | EDGAR | 10K words |
| 2026-01-12 | 0001193125-26-009899 | EDGAR | 2K words |
186 total filings indexed. 154 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001232524 |
| Ticker | JAZZ |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | L2 |
| Website | https://www.jazzpharmaceuticals.com |
| Listed | 2007-06-01 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/JAZZ (~200 tokens, structured JSON with cryptographic provenance)